Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Yoshiaki Masuda"'
Autor:
Kazuyoshi Ikeda, Yuta Maezawa, Tomoki Yonezawa, Yugo Shimizu, Toshiyuki Tashiro, Satoru Kanai, Nobuyoshi Sugaya, Yoshiaki Masuda, Naoko Inoue, Tatsuya Niimi, Keiichi Masuya, Kenji Mizuguchi, Toshio Furuya, Masanori Osawa
Publikováno v:
Frontiers in Chemistry, Vol 10 (2023)
Protein–protein interactions (PPIs) are recognized as important targets in drug discovery. The characteristics of molecules that inhibit PPIs differ from those of small-molecule compounds. We developed a novel chemical library database system (DLiP
Externí odkaz:
https://doaj.org/article/42cbdb75873e4e278b556cd412d3723b
Autor:
Keiko Mori, Yoshiaki Masuda
Publikováno v:
Journal of Japan Academy of Critical Care Nursing. 17:69-79
Publikováno v:
The Proceedings of the Annual Convention of the Japanese Psychological Association. 82:2EV-055
Autor:
Akira Asai, Naoya Suehiro, Yoshiaki Masuda, Daisuke Muraoka, Tatsuya Koseki, Naohisa Ogo, Nao Miyoshi
Publikováno v:
Biologicalpharmaceutical bulletin. 42(5)
Signal transducer and activator of transcription 3 (STAT3) is a latent transcription factor that contributes to tumor cell growth and survival and is often constitutively active in several types of cancers, which makes it an attractive target for can
Autor:
Yoshiaki Masuda, Kaoru Yamano
Publikováno v:
Journal of Rural Problems. 47:96-101
Autor:
Akira Asai, Takane Yokotagawa, Sachiko Tai, Osamu Takahashi, Tadashi Okawara, Hiroshi Sato, Ayumu Muroya, Yasuto Akiyama, Chie Oshita, Masami Otsuka, Yoshiaki Masuda, Tadashi Ashizawa, Yutaka Uehara, Kenji Matsuno, Hidee Ishii, Toshio Furuya, Naohisa Ogo
Publikováno v:
ACS Medicinal Chemistry Letters. 1:371-375
The signal transducer and activator of transcription 3 (STAT3) is considered to be an attractive therapeutic target for oncology drug development. We identified a N-[2-(1,3,4-oxadiazolyl)]-4-quinolinecarboxamide derivative, STX-0119, as a novel STAT3
Publikováno v:
YAKUGAKU ZASSHI. 130:349-354
An important step to promote fragment-based drug design (FBDD) is to find high-quality fragment molecules. Therefore the design of the fragment library is the most crucial stage. In our fragment library, the main considerations are ligand efficiency
Publikováno v:
Journal of Alloys and Compounds. :543-546
Crack-free Pb(Yb 1/2 Nb 1/2 )O 3 –PbTiO 3 (PYN–PT) thin films have been fabricated by the chemical solution deposition. Homogeneous and stable PYN–PT precursor solutions were prepared by selecting appropriate starting metal-organic compounds an
Autor:
Fumiko Hayakawa, Naoto Abe, Masayo Nakamori, Yoshiaki Masuda, Naoko Koizuka, Akiko Okazaki, Chiharu Soga
Publikováno v:
Nippon Eiyo Shokuryo Gakkaishi. 58:323-328
Publikováno v:
Circulation Journal. 68:538-541
Background There is a significant relationship between calcification of the aortic arch (Arch) detected by chest X-ray examination and coronary artery disease (CAD), but the relationship between risk factors, CAD and aortic calcification detected dur